Daniel E. Stange

机构：German Cancer Research Center, Heidelberg University, Helmholtz-Zentrum Dresden-Rossendorf, University Hospital Heidelberg, National Center for Tumor Diseases, University Hospital Carl Gustav Carus, Nationales Centrum für Tumorerkrankungen Dresden, German Cancer Research Center (DKFZ) Dresden, German Cancer Consortium (DKTK) Dresden, Technische Universität Dresden · ORCID：0000-0003-4246-2230

发表论文 150 篇 · 总被引 27475 次 · h-index 43

代表论文

Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The IKF-575/RENAISSANCE phase III trial. (2024 · Journal of Clinical Oncology · 被引 52)
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold (2024 · Molecular Cancer · 被引 52)
Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study (2023 · European Journal of Cancer · 被引 25)
Human assembloids recapitulate periportal liver tissue in vitro (2025 · Nature · 被引 24)
Human liver cholangiocyte organoids capture the heterogeneity of in vivo liver ductal epithelium (2026 · Cell Reports · 被引 6)
MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesis (2025 · Nature Communications · 被引 6)